COVID-19 AND HEART FAILURE

dc.contributor.author	Madazimova D. H.¹, Zhabborov O. O.², Buvamuhammedova N. T.³, Anand Ahudja⁴
dc.date.accessioned	2026-06-05T11:43:52Z
dc.date.available	2026-06-05T11:43:52Z
dc.date.issued	2021
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/4114
dc.description.abstract	Infectious disease caused by the SARS-CoV-2 virus (COVID-19) often occurs in patients with various cardiovascular risk factors and cardiovascular diseases (CVD), which can affect the course of the infectious process. On the other hand, with COVID-19, additional damage to the heart and blood vessels is possible, contributing to the occurrence of cardiovascular complications and aggravation of the course of CVD. This review examines the main facts concerning these interactions, as well as some practical approaches to the management of patients with the simultaneous presence of COVID-19 and cardiovascular pathology	en_US
dc.language.iso	en_US	en_US
dc.publisher	EURASIAN JOURNAL OF ACADEMIC RESEARCH	en_US
dc.subject	COVID-19, cardiovascular diseases, heart failure	en_US
dc.title	COVID-19 AND HEART FAILURE	en_US
dc.type	Article	en_US